BRPI0515443A - combinação de poliquitosamina e de inibidor de hmg-coa reductase para hiperlipidemia - Google Patents

combinação de poliquitosamina e de inibidor de hmg-coa reductase para hiperlipidemia

Info

Publication number
BRPI0515443A
BRPI0515443A BRPI0515443-0A BRPI0515443A BRPI0515443A BR PI0515443 A BRPI0515443 A BR PI0515443A BR PI0515443 A BRPI0515443 A BR PI0515443A BR PI0515443 A BRPI0515443 A BR PI0515443A
Authority
BR
Brazil
Prior art keywords
frequency
channel
digital
audio
stereo
Prior art date
Application number
BRPI0515443-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Andre Aube
Jean-Guy Lehoux
Ryszard Brzezinski
Gilles Dupuis
Original Assignee
Dnp Canada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dnp Canada Inc filed Critical Dnp Canada Inc
Publication of BRPI0515443A publication Critical patent/BRPI0515443A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Stereo-Broadcasting Methods (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI0515443-0A 2004-09-15 2005-09-14 combinação de poliquitosamina e de inibidor de hmg-coa reductase para hiperlipidemia BRPI0515443A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60983004P 2004-09-15 2004-09-15
PCT/CA2005/001406 WO2006029524A1 (en) 2004-09-15 2005-09-14 Combination of polychitosamine and hmg-coa reductase inhibitor for hyperlipidemia

Publications (1)

Publication Number Publication Date
BRPI0515443A true BRPI0515443A (pt) 2008-07-29

Family

ID=36059676

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0515443-0A BRPI0515443A (pt) 2004-09-15 2005-09-14 combinação de poliquitosamina e de inibidor de hmg-coa reductase para hiperlipidemia

Country Status (8)

Country Link
US (5) US20060058261A1 (https=)
EP (1) EP1812019A4 (https=)
JP (1) JP2008513379A (https=)
CN (1) CN101052405A (https=)
AU (1) AU2005284565A1 (https=)
BR (1) BRPI0515443A (https=)
CA (1) CA2580460A1 (https=)
WO (1) WO2006029524A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207646B1 (en) * 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US20080182819A1 (en) * 2007-01-29 2008-07-31 Act Iii Licensing, Llc Chitosan compositions and methods for using chitosan compositions in the treatment of health disorders
KR101913109B1 (ko) 2009-03-18 2018-10-31 리스버로직스 코퍼레이션 신규한 소염제
CN102625705B (zh) 2009-04-08 2015-05-06 南洋理工学院 包含他汀类药物的植物提取物及其制备技术和用途
WO2012171125A1 (en) 2011-06-13 2012-12-20 Rival, Société En Commandite N,n,n-trialkylpolymers, methods of their preparation and uses thereof
JP7437392B2 (ja) * 2018-09-26 2024-02-22 テークー－ジステームス ゲーエムベーハー 電動アシスト自転車の一連の動的制御方法及び装置、電動アシスト自転車
IT201900021291A1 (it) * 2019-11-15 2021-05-15 Biomedica Pharma Gmbh Chitosano e prodotto medicale per l’uso in un metodo di prevenzione o trattamento di una malattia cardiovascolare

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3903140A (en) * 1970-09-08 1975-09-02 Alza Corp Diazadodecane prostaglandin compounds
US4231938A (en) * 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
US4444784A (en) * 1980-08-05 1984-04-24 Merck & Co., Inc. Antihypercholesterolemic compounds
DK149080C (da) * 1980-06-06 1986-07-28 Sankyo Co Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre
US4739073A (en) * 1983-11-04 1988-04-19 Sandoz Pharmaceuticals Corp. Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof
JP3863913B2 (ja) * 1992-12-01 2006-12-27 スリーエム カンパニー 永続性抗菌剤
FI107432B (fi) * 1997-02-06 2001-08-15 Novasso Oy Mikrokiteisen kitosaanin käyttö
FI982291L (fi) * 1998-10-23 2000-04-24 Novasso Oy Aine kolesterolin sekä lipidien pitoisuuden alentamiseksi
US20020016307A1 (en) * 1999-10-27 2002-02-07 Mullins John Jason Gentry Pharmaceutical composition with both a lipase inhibitor and a lipophilic polysaccharide and an improved method for treating adiposity
US6933291B2 (en) * 2000-12-01 2005-08-23 N.V. Nutricia Cholesterol lowering supplement
KR20040026705A (ko) * 2001-08-16 2004-03-31 테바 파마슈티컬 인더스트리즈 리미티드 스타틴의 칼슘 염 형태의 제조 방법
GB0302738D0 (en) * 2003-02-06 2003-03-12 Advanced Biopolymers As Composition

Also Published As

Publication number Publication date
US20090197830A1 (en) 2009-08-06
WO2006029524A1 (en) 2006-03-23
EP1812019A1 (en) 2007-08-01
US20060058261A1 (en) 2006-03-16
AU2005284565A1 (en) 2006-03-23
CN101052405A (zh) 2007-10-10
CA2580460A1 (en) 2006-03-23
JP2008513379A (ja) 2008-05-01
US20120258932A1 (en) 2012-10-11
EP1812019A4 (en) 2007-12-26
US20110028429A1 (en) 2011-02-03
US20130244973A1 (en) 2013-09-19

Similar Documents

Publication Publication Date Title
WO2006084916A3 (en) Parametric joint-coding of audio sources
EP1523132B8 (en) Digital transmission of audio signals
HUE042231T2 (hu) Broadcast és multicast szolgáltatásokra vonatkozó jelzés információ átvitel
WO2009100246A3 (en) Systems, methods, and devices for scanning broadcasts
AU2002240800A1 (en) Electroacoustic conversion of audio signals, especially voice signals
WO2003032148A8 (en) Datacast distribution system
AU2002322503A1 (en) Digital audio/video broadcast on cellular systems
WO2007123788A3 (en) Audio signal processing
AU2003213149A1 (en) Scalable compression of audio and other signals
EP1616424A4 (en) MULTICHANNEL QUADRATURE AMPLITUDE MODULATION WITH WIDE BAND OF CABLE TELEVISION SIGNALS
AU2003298371A1 (en) Secure transmission of audio signals
BRPI0515443A (pt) combinação de poliquitosamina e de inibidor de hmg-coa reductase para hiperlipidemia
GB2388279B (en) Secure transmission of audio signals
AU2003233957A1 (en) Digital video broadcasting receiver
TW200623878A (en) Direct digital encoding and radio frequency modulation for broadcast television application
AU2002306677A1 (en) Dynamic multimedia streaming using time-stamped remote instructions
CN104410946A (zh) 一种无线多设备组合实现多声道输出音频的方法及系统
ATE218022T1 (de) Universelles signalverteilsystem
WO2006020376A3 (en) Method of transmitting audio and video signals overs radio and television channels
ECSP034457A (es) Codificador vsb de bajo costo y modulador fr para suministrar una señal sustancial vsb de 6 mhz a un receptor digital de television
MX2007008932A (es) Peliculas doblables de poliolefina.
AU2003299204A1 (en) Focal calcium channel modulation
WO2008057133A3 (en) Positional linking of analog two-way radios
GB0307448D0 (en) Modulated output of digital audio signals
KR200400113Y1 (ko) 디지털 멀티미디어 방송 디코더

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012.